Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Triptorelin 0.1mg (drug) — also listed as: Decapeptyl 0.1 mg

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ibn Rochd Infertility Centre
  Constantine, Algeria
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• assessment of beta subunit of human chorionic gonadotropin (diagnostic_test)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Obstetrics and Gynecology, Kasr Al-Ainy hospital
  Cairo, Greater Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Sildenafil vaginal suppositories (drug)
• vaginal placebo (other)
• vaginal placebo (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Royan Institute
  Tehrān, Iran
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Endometrial scratch (procedure)
• G-CSF administration (drug)
• Saline Solution (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ganirelix 0.25 mg. (drug) — also listed as: ORGALUTRAN®.
• Recombinant choriogonadotropin alfa (drug) — also listed as: OVITRELLE®.
• Micronized natural progesterone. (drug) — also listed as: PROGEFFIK®.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Human Reproduction Unit of the La Fe University and Politechnic Hospital
  Valencia, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alfa (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hospital Quiron Dexeus
  Barcelona, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Growth Hormone (drug) — also listed as: Somatotropin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Centro de Infertilidad y Reproducción Humana (CIRH)
  Barcelona, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Gonadotropin-Releasing Hormone Analogue (drug)
• Gonadotropin releasing hormone antagonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Self-assessment (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Presidential Women's Center
  West Palm Beach, Florida, United States
  Site recruitment: Not reported
• Carafem
  Chevy Chase, Maryland, United States
  Site recruitment: Not reported
• Philadelphia Women's Center
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pergoveris in long protocol with GnRH agonist (drug) — also listed as: Pergoveris
• Pergoveris in GnRH antagonist protocol (drug) — also listed as: Cetrotide

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University Hospital of Basel
  Basel, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• estrogen (drug) — also listed as: estrodiol
• Low Molecular Weight Heparin (drug) — also listed as: LMWH
• hCG (drug) — also listed as: Human Chorionic Gonadotropin
• progesterone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University
  Guangzhou, Guangdong, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• blood collection (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• IVM (other)
• ICSI (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Levothyroxine (drug) — also listed as: LT4

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Second Affiliated Hospital of Soochow University
  Suzhou, Jiangsu, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Total abdominal hysterectomy and methotrexate (procedure) — also listed as: surgery and chemotherapy
• Methotrexate plus folinic acid alone (drug) — also listed as: chemotharapy

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Mansoura University Hospital
  Al Mansurah, Dakahlia Governorate, Egypt
  Site recruitment: Recruiting
• Maher Elesawi Kamel Elesawi
  Mīt Ghamr, Eldakahlia, Egypt
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Intrauterine insemenation (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Triptorelin for Injection (drug) — also listed as: Gonadotropin releasing hormone agonists
• Recombinant Human Choriogonadotropin alfa Solution for Injection (drug)
• Progesterone Soft Capsules (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The first Affiliated Hospital of Anhui Medical University
  Hefei, Anhui, China
  Site recruitment: Not reported
• Sun Yat-sen Memorial Hospital
  Guangzhou, Guangdong, China
  Site recruitment: Not reported
• The Sixth Affiliated Hospital of Sun Yat-sen University
  Guangzhou, Guangdong, China
  Site recruitment: Not reported
• Xiangya Hospital Central South University
  Changsha, Hunan, China
  Site recruitment: Not reported
• Women's Hospital School of Medicine Zhejiang University
  Hangzhou, Zhejiang, China
  Site recruitment: Not reported
• Peking University Third Hospital
  Beijing, China
  Site recruitment: Not reported
• Jiangsu Province Hospital
  Nanjing, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human chorionic gonadotropin (hCG) (drug) — also listed as: Novarel, human chorionic gonadotropin
• Placebo Comparator (for hCG) (drug) — also listed as: IVF media, "Global" media-trademark

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The Fertility Center , 3230 Eagle Park Drive NE, suite 100
  Grand Rapids, Michigan, United States
  Site recruitment: Not reported